Enrollment continues for first FDA-approved study involving multiple intravenous injections of mesenchymal stem cells for cardiovascular indications SAN DIEGO—Sept. 27, 2019—CardioCell, a biotechnology company that uses allogeneic stem cells for cardiovascular indications, announces the treatment
Read MoreCardioCell and MedStar Heart & Vascular Institute Initiate Phase IIa Clinical Trial to Assess Stem Cell Therapy Effects in Heart Failure Patients With Left Ventricular Assist Devices (LVADs)
News Dec 11, 2018 CardioCell and MedStar Heart & Vascular Institute Initiate Phase IIa Clinical Trial to Assess Stem Cell Therapy Effects in Heart Failure Patients With Left Ventricular Assist Devices (LVADs) FDA approves first study involving multiple intravenous injections of
Read MoreInnovative Stem Cell Therapeutic Strategy May be Transformative for Heart Failure Treatment
News Dec 4, 2018 Innovative Stem Cell Therapeutic Strategy May be Transformative for Heart Failure Treatment Washington, D.C., – The FDA has recently approved an investigational new drug clinical trial that will start shortly at MedStar Heart & Vascular Institute. The trial,
Read MoreCardioCell, in Collaboration With MedStar, Plans Clinical Trial That May Transform Therapy for Terminal Heart Failure Patients
News Apr 25, 2018 CardioCell, in Collaboration With MedStar, Plans Clinical Trial That May Transform Therapy for Terminal Heart Failure Patients SAN DIEGO — April 25, 2018 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for
Read MoreNew Stem Cell Therapy May Transform Heart Failure Treatment
News Apr 18, 2018 New Stem Cell Therapy May Transform Heart Failure Treatment Washington, D.C., April 18, 2018 – Clinical trial planning is underway at MedStar Heart & Vascular Institute to determine whether a novel stem cell therapy will improve heart function for patients with
Read MorePositive Results From Pre-Clinical Studies Sponsored by CardioCell Post in the American Heart Association’s Journal “Circulation Research”
News Feb 23, 2017 Positive Results From Pre-Clinical Studies Sponsored by CardioCell Post in the American Heart Association’s Journal “Circulation Research” SAN DIEGO — Feb. 23, 2017 — Results from an acute myocardial infarction and an ischemic cardiomyopathy pre-clinical study
Read More
Circulation Research, a Journal of the American Heart Association
News Feb 23, 2017 Circulation Research, a Journal of the American Heart Association Results from CardioCell’s pre-clinical studies are featured in a peer-reviewed article now available in the American Heart Association’s journal Circulation Research. Entitled “Intravenously-Delivered
Read More
Circulation Research, a Journal of the American Heart Association
News Jan 23, 2017 Circulation Research, a Journal of the American Heart Association Dr. Jay H. Traverse, MD, FACC, FAHA, cited CardioCell's Phase IIa chronic heart failure clinical trial results in an editorial in the January issue of the American Heart Association’s
Read More